United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News XR Immersive Tech clarifies SVR licensing structure after deal termination and CSE review XR Immersive Tech clarifies SVR licensing and exits CGM deal. Find out how these moves reshape its 2025 revenue model and investor outlook. byPallavi MadhirajuJune 30, 2025